Active ingredient
Romiplostim
3 finished FDA listings contain Romiplostim as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ROMIPLOSTIM
- Dosage forms
- Injection, Powder, Lyophilized, For Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 125 ug/.25ml · 250 ug/.5ml · 500 ug/ml
- Brand names in FDA listings
- Nplate
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 805452
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 125268 | AMGEN | 2008-08-22 | 3 |
Official labeling on DailyMed
- NPLATE (ROMIPLOSTIM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AMGEN, INC] · version 162 · 2026-06-26
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.